` 4967 (Kobayashi Pharmaceutical Co Ltd) vs Nikkei 225 Comparison - Alpha Spread

4967
vs
Nikkei 225

Over the past 12 months, has underperformed Nikkei 225, delivering a return of -6% compared to the Nikkei 225's 2% drop.

Stocks Performance
4967 vs Nikkei 225

Loading
4967
Nikkei 225
Add Stock
www.alphaspread.com

Performance Gap
4967 vs Nikkei 225

Loading
4967
Nikkei 225
Difference
www.alphaspread.com

Performance By Year
4967 vs Nikkei 225

Loading
4967
Nikkei 225
Add Stock

Competitors Performance
Kobayashi Pharmaceutical Co Ltd vs Peers

Nikkei 225
4967
OR
ULVR
HINDUNILVR
HLN
Add Stock

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
391.6B JPY
Industry
Consumer products

In the bustling landscape of Japanese business, Kobayashi Pharmaceutical Co., Ltd. stands as an epitome of innovation and tradition. Founded in 1886, this company, steeped in history, has consistently demonstrated a knack for transforming simple consumer needs into thriving business opportunities. Core to its operations is the development, manufacturing, and marketing of consumer healthcare products that subtly blend pharmaceutical expertise with daily convenience. This approach has allowed Kobayashi Pharmaceutical to carve out a distinctive niche, particularly in over-the-counter (OTC) health and personal care products. The company's vast array of products is remarkably diverse, ranging from cooling gel sheets for fevers to herbal medicinal drinks, each crafted with an understanding of consumer pain points and a commitment to well-being. What sets Kobayashi apart in the competitive market is its strategic focus on niche products that serve unmet needs. This laser-sharp business model does more than just bolster its domestic market; it drives its global expansion into key markets in Asia, North America, and Europe. The company's profitability hinges not just on innovation but also on its agile response to the shifting preferences of health-conscious consumers. Driven by a mission to deliver "small but valuable products," Kobayashi’s nimble approach, coupled with an impressive R&D focus, ensures that it remains at the forefront of both consumer satisfaction and shareholder value. Much like a well-crafted Japanese garden, every part of Kobayashi's operation is meticulously designed to function harmoniously, making it a standout player in the global consumer healthcare industry.

Intrinsic Value
6 345.74 JPY
Undervaluation 17%
Intrinsic Value
Price
Back to Top